Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions emphasize the importance of open access for research visibility and cite the miR-204 study's citations and publication details, indicating awareness of its scholarly impact, whereas collective tone remains informational more than critically analytical, reflecting moderate engagement and impact.
Most discussions highlight the importance of open access and the significance of miR-204 research, showing general support for the publication's themes.
Posts express moderate curiosity about the research, focusing more on open access policies and citation mentions rather than detailed scientific content.
While some users share citations and summarize research highlights, there is limited deep discussion or technical analysis of the findings.
The dissemination of research through citations and open access promotion suggests a recognition of its potential influence, though discussions remain somewhat superficial.
My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was accepted a year ago in #AACR #CancerResearch and has been cited at least once. Check it out while you're at #AACR19 #AACR2019. #cancer https://t.co/ceAAncKIWa
#OpenAccess #OA is important for maximizing the impact of #research and scholarly #publications. #OpenAccessWeek #OAWeek #OAWeek2020 is going to take place on 19 - 25 October. Make sure you understand beforehand what Open Access is about with this video: https://t.co/RfCqcKukfa
My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was published in print a year ago in #AACR #CancerResearch and has been cited at least three times. #cancer https://t.co/ceAAncKIWa
I'm happy to announce that I received the very first citation for my #PhD #research on tumour suppressor #microRNA miR-204, which is first published online almost a year ago on #AACR #CancerResearch. You can read my article here: https://t.co/ceAAncKIWa #MYCN #neuroblastoma
My first research article has been cited by 13 scientific publications since it was first published online in @AACR #CancerResearch 2 yrs ago, according to Google Scholar. Thanks to everyone involved #cancer #ChildhoodCancer #microRNA #neuroblastoma #AACR https://t.co/ceAAncKIWa
RT @OoiChiYan: My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was published in p…
Network modeling reveals miR-204 as a tumor suppressor inhibiting MYCN in neuroblastoma, highlighting potential therapeutic targets to control tumor growth.
Since 2009 Open Access Week takes place every year in the last full week of October. This video explores the concept of Open Access and why it is important for the scientific community and the public.
This week is #OpenAccessWeek #OAweek. Not all #OpenAccess #OA publications are created equal. Learn more in this video: https://t.co/RfCqcKukfa
RT @OoiChiYan: #OpenAccess #OA is important for maximizing the impact of #research and scholarly #publications. #OpenAccessWeek #OAWeek #OA…
RT @OoiChiYan: #OpenAccess #OA is important for maximizing the impact of #research and scholarly #publications. #OpenAccessWeek #OAWeek #OA…
#OpenAccess #OA is important for maximizing the impact of #research and scholarly #publications. #OpenAccessWeek #OAWeek #OAWeek2020 is going to take place on 19 - 25 October. Make sure you understand beforehand what Open Access is about with this video: https://t.co/RfCqcKukfa
RT @OoiChiYan: My first research article has been cited by 13 scientific publications since it was first published online in @AACR #Cancer…
My first research article has been cited by 13 scientific publications since it was first published online in @AACR #CancerResearch 2 yrs ago, according to Google Scholar. Thanks to everyone involved #cancer #ChildhoodCancer #microRNA #neuroblastoma #AACR https://t.co/ceAAncKIWa
For those without access to subscriptions, #OpenAccess is vital avenue for accessing #knowledge from scholarly publications. But not all #OA publications are created equal. Know more before #OpenAccessWeek #OAweek begins next week: https://t.co/RfCqcKukfa https://t.co/NhfuzuxIgA
The last full week of #October is #OpenAccessWeek #OAweek. Learn about what #OpenAccess #OA of scholarly publications really means and its roles in maximizing the #impact and benefits of #research to the world: https://t.co/RfCqcKukfa https://t.co/NhfuzuxIgA #creativecommons
RT @OoiChiYan: My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was published in p…
My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was published in print a year ago in #AACR #CancerResearch and has been cited at least three times. #cancer https://t.co/ceAAncKIWa
This year marks the 10th anniversary of #OpenAccessWeek. My @YouTube video on #OpenAccess can act as a primer to understand the policy of certain political party before you vote https://t.co/RfCqcKukfa
RT @OoiChiYan: My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was accepted a yea…
My paper on #tumour suppressor #microRNA miR-204 as inhibitor of #MYCN in #ChildhoodCancer #neuroblastoma was accepted a year ago in #AACR #CancerResearch and has been cited at least once. Check it out while you're at #AACR19 #AACR2019. #cancer https://t.co/ceAAncKIWa
I'm happy to announce that I received the very first citation for my #PhD #research on tumour suppressor #microRNA miR-204, which is first published online almost a year ago on #AACR #CancerResearch. You can read my article here: https://t.co/ceAAncKIWa #MYCN #neuroblastoma
O仁
UP
S